Skip to Main Content

Author Details

Carel B Hoyng
Radboud University Medical Center
1989
378
71
PMIDPaper TitleJournal TitlePublished Year
37598860Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.Ophthalmology2024
37749859Quality of life in patients with CRB1-associated retinal dystrophies: A longitudinal study.Acta Ophthalmol2024
37934290Clinical classification of Stargardt disease.Graefes Arch Clin Exp Ophthalmol2024
34348923Charles Bonnet syndrome in patients with Stargardt disease: prevalence and risk factors.Br J Ophthalmol2023
37580831Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8.Eye Vis (Lond)2023
37979432Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A.Stem Cell Res2023
37410486Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis.JAMA Ophthalmol2023
37441824Generation of iPSC lines from three Stargardt patients carrying bi-allelic ABCA4 variants.Stem Cell Res2023
37036511Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol2023
37367859Systemic Metabolomics in a Framework of Genetics and Lifestyle in Age-Related Macular Degeneration.Metabolites2023
37334034Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2a.Ophthalmol Sci2023
37294701Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel.Transl Vis Sci Technol2023
36723966Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1.Transl Vis Sci Technol2023
36785559Whole genome sequencing for <i>USH2A</i>-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction.HGG Adv2023
36764426Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.Am J Ophthalmol2023
36727801INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.Retina2023
36524988Optical genome mapping and revisiting short-read genome sequencing data reveal previously overlooked structural variants disrupting retinal disease-associated genes.Genet Med2023
36036675Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study.Acta Ophthalmol2023
36202933Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.Graefes Arch Clin Exp Ophthalmol2023
36252678Outcome of Cataract Surgery in Patients With Retinitis Pigmentosa.Am J Ophthalmol2023
34320374CRB1-Associated Retinal Dystrophies: A Prospective Natural History Study in Anticipation of Future Clinical Trials.Am J Ophthalmol2022
37645124The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients.Open Res Eur2022
35379979Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial.Nat Med2022
35672333Scrutinizing pathogenicity of the USH2A c.2276â¿¿Gâ¿¿&gt;â¿¿T; p.(Cys759Phe) variant.NPJ Genom Med2022
35608844Identification of a Complex Allele in IMPG2 as a Cause of Adult-Onset Vitelliform Macular Dystrophy.Invest Ophthalmol Vis Sci2022
35499594[Treatment of age-related macular degeneration: new insights and developments].Ned Tijdschr Geneeskd2022
35533974Spontaneous Resolution of Chronic Central Serous Chorioretinopathy: "Fuji Sign".Ophthalmol Retina2022
35526389Generation of an iPSC line (SCTCi015-A) and isogenic control line (SCTCi015-A-1) from an age-related macular degeneration patient carrying the variant c.355G&gt;A in the CFI gene.Stem Cell Res2022
35526386Generation of an iPSC line (SCTCi014-A) and isogenic control line (SCTCi014-A-1) from an age-related macular degeneration patient carrying the variant c.355G&gt;A in the CFI gene.Stem Cell Res2022
37089696Analysis of hemopexin plasma levels in patients with age-related macular degeneration.Mol Vis2022
35925583Phenotypic Expression of CFH Rare Variants in Age-Related Macular Degeneration Patients in the Coimbra Eye Study.Invest Ophthalmol Vis Sci2022
36053979Common and rare variants in patients with early onset drusen maculopathy.Clin Genet2022
33910932<i>BBS1</i> branchpoint variant is associated with non-syndromic retinitis pigmentosa.J Med Genet2022
35314386The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.Ophthalmol Retina2022
35069568Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome.Front Immunol2022
35063911Generation and characterization of human induced pluripotent stem cells (iPSCs) from three patients with age-related macular degeneration carrying rare variants in the CFH gene.Stem Cell Res2022
35240203The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.Ophthalmology2022
35142031Imaging diabetic retinal disease: clinical imaging requirements.Acta Ophthalmol2022
35266249Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.Hum Mutat2022
35262734Evaluation of Local Rod and Cone Function in Stargardt Disease.Invest Ophthalmol Vis Sci2022
34864802EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.Retina2022
35078129Generation and characterization of human induced pluripotent stem cells (iPSCs) from three individuals without age-related macular degeneration.Stem Cell Res2022
34431609Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry.Acta Ophthalmol2022
34624300X-Linked Retinoschisis: Novel Clinical Observations and Genetic Spectrum in 340 Patients.Ophthalmology2022
34508573Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene.Hum Mol Genet2022
34214454Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.Am J Ophthalmol2022
30824420Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.Br J Ophthalmol2021
36246952Genetic Risk in Families with Age-Related Macular Degeneration.Ophthalmol Sci2021
33907369Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near <i>MMP9</i>.Mol Vis2021
33849814Commentary on "Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes".Redox Biol2021
  • 1 - 50 of 378

Recommended Authors

LuEsther T. Mertz Retinal Research Center and Manhattan Eye, and Throat Hospital
Career Start Year 2017
Number of shared co-authors 10
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2014
Number of shared co-authors 10
Institute for Vision Research, Carver College of Medicine, University of Iowa
Career Start Year 2012
Number of shared co-authors 3
University of Western Australia
Career Start Year 2011
Number of shared co-authors 14
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 7
Retinal Research Institute LLC
Career Start Year 2009
Number of shared co-authors 2
University of Manchester
Career Start Year 2009
Number of shared co-authors 24
Shiley Eye Institute, University of California
Career Start Year 2007
Number of shared co-authors 14
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2006
Number of shared co-authors 14
University of Washington
Career Start Year 2006
Number of shared co-authors 4
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 24
National Eye Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 20
Shiley Eye Institute, Rady Children's Hospital, University of California
Career Start Year 2004
Number of shared co-authors 3
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 29
Duke University Medical Center
Career Start Year 2002
Number of shared co-authors 21
Singapore Eye Research Institute
Career Start Year 2002
Number of shared co-authors 24
Novartis Pharma AG
Career Start Year 2001
Number of shared co-authors 15
Institute for Vision Research, Carver College of Medicine, University of Iowa
Career Start Year 2000
Number of shared co-authors 14
Universite de Poitiers, INSERM 4 Department of Ophthalmology
Career Start Year 2000
Number of shared co-authors 35
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Career Start Year 2000
Number of shared co-authors 20
Unit on Clinical Investigation of Retinal Disease, National Eye Institute
Career Start Year 2000
Number of shared co-authors 18
Moorfields Eye Hospital Dubai.
Career Start Year 1999
Number of shared co-authors 58
Royal Victoria Infirmary
Career Start Year 1999
Number of shared co-authors 19
Royal Perth Hospital
Career Start Year 1997
Number of shared co-authors 16
University of Arizona College of Medicine
Career Start Year 1996
Number of shared co-authors 19
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 7
Shiley Eye Institute, University of California San Diego
Career Start Year 1993
Number of shared co-authors 26
the University of Iowa Carver College of Medicine
Career Start Year 1993
Number of shared co-authors 26
University of Illinois at Chicago
Career Start Year 1986
Number of shared co-authors 13
University of Illinois at Chicago
Career Start Year 1971
Number of shared co-authors 40

Collaborators

Erasmus Medical Center
Co-authored papers 60
Radboud University Medical Center
Co-authored papers 29
National Eye Institute, National Institutes of Health.
Co-authored papers 17
University of Bonn
Co-authored papers 15
University of Paris Est-Creteil
Co-authored papers 12
Radboud University Medical Center
Co-authored papers 10
Maastricht University Medical Centre
Co-authored papers 9
Erasmus University Medical Center
Co-authored papers 9
University of Bonn
Co-authored papers 9
Radboud University Medical Center
Co-authored papers 9
University of Southampton
Co-authored papers 9
Queen's University Belfast
Co-authored papers 8
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers 7
Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital
Co-authored papers 7
Casey Eye Institute at Oregon Health & Science University (OHSU)
Co-authored papers 6
Co-authored papers 6
Institute of Ophthalmology, University College London
Co-authored papers 6
Columbia University Medical Center
Co-authored papers 6
Erasmus Medical Center
Co-authored papers 6
Institute of Ophthalmology, University College London
Co-authored papers 6
Doheny Eye Institute, University of California Los Angeles
Co-authored papers 6
Retina Foundation of the Southwest
Co-authored papers 5
Leeds Teaching Hospitals NHS Trust
Co-authored papers 5
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Co-authored papers 4
Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
University Eye Hospital, University of Tubingen
Co-authored papers 4
University of Oxford
Co-authored papers 4
Co-authored papers 4
Jules Stein Eye Institute
Co-authored papers 4
Co-authored papers 4